Gilead Calistoga LLC

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gilead Calistoga LLC.The latest application filed is for "therapies for hematologic malignancies".

Company Profile

9.30.35

Gilead Calistoga LLC - Foster City CA US
GILEAD CALISTOGA LLC - Fosster City CA US
Gilead Calistoga, LLC. - Foster City CA
Gilead Calistoga LLC; - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Process methods for phosphatidylinositol 3-kinase inhibitors Grant 10,954,199 - Bremner , et al. March 23, 2	2021-03-23
Therapies For Hematologic Malignancies App 20200368243 - GALLATIN; W. Michael ; et al.	2020-11-26
Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-on- e Grant 10,730,879 - Carra , et al.	2020-08-04
Process Methods For Phosphatidylinositol 3-kinase Inhibitors App 20200102277 - BREMNER; Stacy ; et al.	2020-04-02
Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-on- e Grant 10,442,805 - Buttar , et al. Oc	2019-10-15
Process methods for phosphatidylinositol 3-kinase inhibitors Grant 10,414,737 - Bremner , et al. Sept	2019-09-17
Therapies For Hematologic Malignancies App 20190083498 - GALLATIN; W. Michael ; et al.	2019-03-21
Process Methods For Phosphatidylinositol 3-kinase Inhibitors App 20190031626 - BREMNER; Stacy ; et al.	2019-01-31
Therapies for hematologic malignancies Grant 10,154,998 - Gallatin , et al. Dec	2018-12-18
Process for preparing phosphatidylinositol 3-kinase inhibitors and intermediates thereof Grant 10,059,677 - Bremner , et al. August 28, 2	2018-08-28
Process methods for phosphatidylinositol 3-kinase inhibitors Grant 10,047,060 - Bremner , et al. August 14, 2	2018-08-14
Process Methods For Phosphatidylinositol 3-kinase Inhibitors App 20180162826 - BREMNER; Stacy ; et al.	2018-06-14
Polymorphic Forms Of A Hydrochloride Salt Of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-on- E App 20180009811 - BUTTAR; Suzanne ; et al.	2018-01-11
Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-on- e Grant 9,708,327 - Buttar , et al. July 18, 2	2017-07-18
Combination Therapies For Hematologic Malignancies App 20170119771 - GALLATIN; W. Michael ; et al.	2017-05-04
Therapies For Hematologic Malignancies App 20170112841 - GALLATIN; W. Michael ; et al.	2017-04-27
Process Methods For Phosphatidylinositol 3-kinase Inhibitors App 20170107187 - BREMNER; Stacy ; et al.	2017-04-20
Process methods for phosphatidylinositol 3-kinase inhibitors Grant 9,567,337 - Bremner , et al. February 14, 2	2017-02-14
Polymorphic Forms Of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-on- E App 20160376274 - Carra; Ernest ; et al.	2016-12-29
Therapies for hematologic malignancies Grant 9,492,449 - Gallatin , et al. November 15, 2	2016-11-15
Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-on- e Grant 9,469,643 - Carra , et al. October 18, 2	2016-10-18
Phosphatidylinositol 3-kinase inhibitors Grant 9,266,878 - Evarts , et al. February 23, 2	2016-02-23
Phosphatidylinositol 3-kinase Inhibitors App 20160016915 - Evarts; Jerry ; et al.	2016-01-21
Therapies for hematologic malignancies Grant 9,238,070 - Gallatin , et al. January 19, 2	2016-01-19
Phosphatidylinositol 3-kinase Inhibitors App 20150218154 - Evarts; Jerry ; et al.	2015-08-06
Combination Therapies For Hematologic Malignancies App 20150196564 - GALLATIN; W. Michael ; et al.	2015-07-16
Process Methods For Phosphatidylinositol 3-kindase Inhibitors App 20150175605 - Bremner; Stacy ; et al.	2015-06-25
Polymorphic Forms Of A Hydrochloride Salt Of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-on- E App 20150175606 - Buttar; Suzanne ; et al.	2015-06-25
Phosphatidylinositol 3-kinase inhibitors Grant 9,029,384 - Evarts , et al. May 12, 2	2015-05-12
Phosphatidylinositol 3-kinase inhibitors Grant 9,018,221 - Evarts , et al. April 28, 2	2015-04-28
Polymorphic Forms Of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-on- E App 20150080572 - CARRA; Ernest ; et al.	2015-03-19
Therapies For Hematologic Malignancies App 20140323439 - GALLATIN; W. Michael ; et al.	2014-10-30
Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-on- e Grant 8,865,730 - Carra , et al. October 21, 2	2014-10-21
Phosphatidylinositol 3-kinase Inhibitors App 20140179673 - EVARTS; Jerry ; et al.	2014-06-26
Phosphatidylinositol 3-kinase Inhibitors App 20140179718 - EVARTS; Jerry ; et al.	2014-06-26
Treatment of liver disorders with PI3K inhibitors Grant 8,691,829 - Ulrich April 8, 2	2014-04-08
Therapies For Hematologic Malignancies App 20140066386 - GALLATIN; W. Michael ; et al.	2014-03-06
Therapies For Treating Cancer App 20140051696 - LANNUTTI; Brian J. ; et al.	2014-02-20
Methods Of Treatment For Solid Tumors App 20130344138 - PURI; Kamal D. ; et al.	2013-12-26
Methods of treatment for solid tumors Grant 8,546,409 - Puri , et al. October 1, 2	2013-10-01
Polymorphic Forms Of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-on- E App 20130252976 - CARRA; Ernest ; et al.	2013-09-26
Compositions And Methods Of Treating A Proliferative Disease With A Quinazolinone Derivative App 20130143902 - Evarts; Jerry B. ; et al.	2013-06-06
Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use Grant 8,440,677 - Evarts , et al. May 14, 2	2013-05-14
Therapies For Hematologic Malignancies App 20130071323 - Gallatin; W. Michael ; et al.	2013-03-21
Combination Therapies For Hematologic Malignancies App 20130064812 - GALLATIN; W. Michael ; et al.	2013-03-14
Treatment Of Liver Disorders With P13k Inhibitors App 20120178767 - Ulrich; Roger G.	2012-07-12